Future of Life Institute Podcast

Emilia Javorsky is a physician-scientist and Director of the Futures Program at the Future of Life Institute. 
She joins the podcast to discuss her newly published essay on AI and cancer. She challenges tech claims that superintelligence will cure cancer, explaining why biology’s complexity, poor data, and misaligned incentives are bigger bottlenecks than raw intelligence. The conversation covers realistic roles for AI in drug discovery, clinical trials, and cutting unnecessary medical bureaucracy.

You can read the full essay at: curecancer.ai


CHAPTERS:
(00:00) Episode Preview
(01:10) Introduction and essay motivation
(06:30) Intelligence vs data bottlenecks
(19:03) Cancer's complexity and heterogeneity
(29:05) Measurement, health, and homeostasis
(41:41) AI in drug development
(50:13) Regulation, FDA, and innovation
(01:02:58) Practical paths toward cures


PRODUCED BY:
https://aipodcast.ing


SOCIAL LINKS:
Website: https://podcast.futureoflife.org
Twitter (FLI): https://x.com/FLI_org
Twitter (Gus): https://x.com/gusdocker
LinkedIn: https://www.linkedin.com/company/future-of-life-institute/
YouTube: https://www.youtube.com/channel/UC-rCCy3FQ-GItDimSR9lhzw/
Apple: https://geo.itunes.apple.com/us/podcast/id1170991978
Spotify: https://open.spotify.com/show/2Op1WO3gwVwCrYHg4eoGyP


What is Future of Life Institute Podcast?

The Future of Life Institute (FLI) is a nonprofit working to reduce global catastrophic and existential risk from powerful technologies. In particular, FLI focuses on risks from artificial intelligence (AI), biotechnology, nuclear weapons and climate change. The Institute's work is made up of three main strands: grantmaking for risk reduction, educational outreach, and advocacy within the United Nations, US government and European Union institutions. FLI has become one of the world's leading voices on the governance of AI having created one of the earliest and most influential sets of governance principles: the Asilomar AI Principles.